Apellis Pharmaceuticals Inc (APLS)
33.32
+0.11
(+0.33%)
USD |
NASDAQ |
Dec 24, 16:00
Apellis Pharmaceuticals Cash from Investing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen Inc | -1.181B |
| Biomarin Pharmaceutical Inc | -16.16M |
| Ionis Pharmaceuticals Inc | -340.80M |
| QuidelOrtho Corp | -56.50M |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 34.10M |
| Cash from Financing (Quarterly) | 2.542M |
| Free Cash Flow | -205.58M |
| Free Cash Flow Per Share (Quarterly) | 0.2745 |
| Free Cash Flow to Equity (Quarterly) | 39.06M |
| Free Cash Flow to Firm (Quarterly) | 43.84M |
| Free Cash Flow Yield | -5.01% |